SLAMF7 Polyclonal Antibody

• Background:

  SLAM family member 7 (SLAMF7), also known as CRACC, CD319, CD2-like receptor-activating cytotoxic cells, and CS1, is a single-pass type I membrane protein and a member of the CD2 family of cell surface receptors. SLAMF7 is expressed on the surface of NK cells, CD8+ T cells, activated B cells, and mature dendritic cells but not in promyelocytic, B-cell lines, or T-cell lines. In human NK cells, activated SLAMF7 transmits signals following association with the adaptor protein EAT-2 . In the absence of EAT-2, SLAMF7 potently inhibited natural killer cell function. It was also inhibitory in T cells, which are typically devoid of EAT-2. Thus, SLAMF7 can exert activating or inhibitory influences on cells of the immune system depending on cellular context and the availability of effector proteins.

• Description:

  This is a SLAMF7 Polyclonal Antibody from Reddot Biotech. This product is for Research Use Only.

• Synonyms:

  SLAMF7,19A, CD319, CRACC, CS1

• Gene ID:

  57823

• Swiss Prot:

  Q9NQ25

• Reactivity:

  Human, Mouse

• Immunogen:

  Recombinant fusion protein of human SLAMF7

• Clonality:

  Polyclonal

• Conjugation:

  Unconjugated

• Type:

  Polyclonal Antibody

• Applications:

  WB

• Purification Method:

  Affinity purification

• Assay Type:

  Antibody

• Concentration:

  1mg/mL

• Dilution:

  WB 1:500-1:2000

• Buffer:

  PBS with 0.01% thiomersal,50% glycerol, pH7.3.

• Storage Conditions:

  Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.

• Calculated Molecular Weight:

  29kDa/33kDa/34kDa

• Observed Molecular Weight:

  45kDa

• Host or Source:

  Rabbit

• Isotype:

  IgG